Nutex Health Inc.

NASDAQ: NUTX · Real-Time Price · USD
92.91
-18.22 (-16.40%)
At close: Aug 15, 2025, 3:59 PM
94.04
1.22%
After-hours: Aug 15, 2025, 07:49 PM EDT

Nutex Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
211.79M 257.62M 78.79M 76.08M 67.45M 69.67M 62.72M 58.92M 56.33M 53.72M 28.4M 58.05M 6.21M 65.03M 117.97M 62.81M 2.01M
Cost of Revenue
93.45M 115.99M 56.88M 53.52M 57.3M 56.46M 55.66M 49.28M 51.48M 53.19M 54.86M 53.06M 4.49M 64.75M 41.96M 33.68M 1.59M
Gross Profit
118.34M 141.63M 21.92M 22.56M 10.16M 13.21M 7.07M 9.65M 4.85M 530.32K -26.47M 4.99M 1.72M 271.85K 76.01M 29.14M 426.87K
Operating Income
72.21M 114.21M 9.66M 5.3M 1.45M 4.08M -777.76K -362.54K -4.45M -5.78M -439.01M 3.91M -16.37M 18.43M 74.46M 27.6M -4.15M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 368.00 n/a 270.00 245.00 114.00
Pretax Income
62.76M 108.58M -2.58M 3.9M -152.82K -30.71M -4.87M -5.08M -7.83M -8.85M -441.78M -3.82M -16.58M 14.62M 74.95M 30.16M -4.48M
Net Income
44.22M 61.7M -8.79M -364.05K -364.07K -31.62M -5.54M -3.48M -5.15M -10.66M -433.24M -23.48M -16.57M 15.06M 53.79M 27.06M -4.44M
Selling & General & Admin
10.04M 27.43M 11.83M 10.59M 8.71M 9.14M 7.84M 10.01M 9.08M 6.31M 4.08M 2.49M 17.79M -103.33M 1.55M 1.53M 4.44M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a -73.75K n/a n/a 73.75K 209.16K 72.27K 59.63K 76.72K
Other Expenses
n/a -11.64K 425.22K 6.67M n/a n/a 53.21K n/a 217.27K 73.75K n/a n/a 216.45K -1.87M 1.75M 4.06M 64.04K
Operating Expenses
10.04M 27.42M 12.25M 17.26M 8.71M 9.14M 7.84M 10.01M 9.29M 6.31M 4.08M 2.49M 18.08M -109.21M 1.55M 1.53M 4.58M
Interest Expense
6.12M 5.05M 5.38M 5.05M 4.44M 4.24M 4.1M 4.84M 3.14M 2.86M 3.4M 4.37M 1.86M 1.94M 1.26M 1.5M 334.33K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 11.05K n/a n/a n/a 9.74K
Cost & Expenses
103.49M 143.41M 69.13M 70.78M 66M 65.59M 63.5M 59.29M 60.77M 59.5M 58.94M 55.54M 22.58M 43.04M 43.51M 35.21M 6.16M
Income Tax Expense
18.54M 8.61M 4.58M 893.89K 389.67K -3M -342.26K -815.61K -910.66K 1.81M -8.54M 19.65M -8.89K -440.18K 453.62K 481.5K -39.58K
Shares Outstanding (Basic)
5.1M 5.1M 5.1M 4.97M 4.5M 4.02M 3.69M 3.56M 4.05M 4.53M 4.33M 4.29M 3.95M 4.66M 3.98M 3.95M 3.95M
Shares Outstanding (Diluted)
5.1M 5.1M 5.1M 4.97M 4.6M 4.22M 4.43M 4.38M 4.65M 4.92M 4.33M 4.31M 3.95M 3.95M 3.95M 3.95M 3.95M
EPS (Basic)
8.67 11.95K -1.72K -0.07 -0.08 -7.86 -1.5 -0.98 -1.27 -2.35 -100.04 -5.48 -4.19 3.23 13.50 6.85 -1.12
EPS (Diluted)
8.67 11.95K -1.72K -0.07 -0.08 -7.5 -1.25 -0.79 -1.11 -2.17 -100.04 -5.45 -4.19 3.81 13.61 6.85 -1.12
EBITDA
73.98M 118.91M 7.77M 13.49M 8.48M -21.79M 3.98M 3.81M -698.79K -2.67M -423.33M 3.26M -15.67M -2.03M -46.76K -558.05K -4.08M
EBIT
n/a 113.63M 2.8M 8.96M 4.29M -26.47M -768.02K -239.01K -4.69M -5.99M -428.05M 24.75K 29.24M -2.26M -239.86K 27.6M -4.15M
Depreciation & Amortization
5.09M 5.28M 4.97M 4.53M 4.19M 4.68M 4.75M 4.18M 3.99M 3.32M 4.33M 3.24M 218.02K 230.52K 193.1K 203.58K 65.1K